RGC

Healthcare Drug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings Limited

$6.82

+0.45 +7.06% today

Price History

Not enough data

Key Stats

Market Cap

3.37B

Avg Volume

232,146

EPS

-$0.01

52W High

$69.00

52W Low

$4.51

Div. Yield

0.0%

Valuation

P/B Ratio

3410.00

EV/EBITDA

-477.01

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(177.7%)

Return on Assets

(85.0%)

Liquidity & Leverage

Current Ratio

1.42

Quick Ratio

1.42

Debt / Equity

0.32

Total Cash

2.36M

Total Debt

386,302

About

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.